Vaccine cold chain pioneers inaugurate new factory extension
Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters.
The factory extension...
Pfizer COVID vaccine demonstrates excellent efficacy against all variants
A novel study has revealed that two doses of the Pfizer COVID vaccine achieve 90% effectiveness against hospitalisations for at least six months against...
Prioritising preventative treatments for postmenopausal osteoporosis
Michael Smith, Managing Director of MyBones, discusses how Low-intensity Vibration could prevent the development of osteoporosis.
Treating postmenopausal women with Low-intensity Vibration (LiV) could strengthen...
UK award substantial funding to safeguard adult social care this winter
The UK government has revealed that it will be providing considerable funding to support the adult social care sector throughout winter, a particularly challenging...
Exploring the issues surrounding vaccinating children against COVID-19
As the US and many European countries start vaccinating children against COVID-19, should more be done to prioritise those beyond our borders? Dominic Wilkinson,...
Improving patient safety and outcomes in high-risk surgery
A team of world-leading medical experts have collaborated to improve patient safety and outcomes following high-risk surgery.
The endeavour, which includes industry specialists such as...
COVID-19 negatively impacts physical activity levels for older adults
Luke Price, Senior Programme Manager at the Centre for Ageing Better, spoke to Health Europa about the physical activity levels for older adults during...
Pioneering research reveals how liver fat affects heart health
A groundbreaking study conducted by researchers at AMRA Medical has identified the impacts that varying visceral and liver fat levels can have on cardiometabolic...
Shedding light on the world of UVC disinfection technologies
Tristan Williams, Technical Director of Finsen Tech Group outlines key aspects to consider when purchasing UVC disinfectant products.
Tristan Williams, Technical Director of Finsen Tech...
CRP rapid testing for suspected COVID-19 could slow the spread of antimicrobial resistance
Dr Carl Llor reviews recent evidence that C-reactive protein (CRP) rapid testing can be used as a prognostic marker in COVID-19 and contribute to...
Defence Therapeutics embark on next stage of breast cancer treatment development
In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
Risk of type 2 diabetes reduced by excellent heart health
A novel study has indicated that middle-aged adults with good heart health are less likely to develop type 2 diabetes in their lifetime, a...
Effectively mitigating the impacts of mucormycosis
Martin Hoenigl, the President of the European Confederation of Medical Mycology, discusses the challenges of diagnosing and treating mucormycosis.
Mucormycosis is perhaps not a term...
Important discussion on the ability to treat chronic kidney disease
Helen Yeh, Vice President of the CVRM Therapy Area, BioPharmaceuticals Medical, at AstraZeneca speaks to Health Europa about the burden and treatment of chronic kidney disease.
Chronic spontaneous urticaria: could the answer be in CBD?
Dr Sari Prutchi Sagiv, CSO of Stero Biotechs, explains why CBD could be a potential treatment for chronic spontaneous urticaria.
Urticaria can be caused by...
A new hope for treating neurodegenerative diseases
NervGen’s NVG-291 is a new drug with the potential to treat a range of neurodegenerative diseases, including Alzheimer's and MS.
IT is the Holy Grail...
Harnessing the benefits of UVA light treatment in COVID-19 patients
Following a first-in-human study which analysed the efficacy of UVA light treatment in COVID-19 patients, Health Europa spoke to Dr Ali Rezaie from the academic healthcare organisation, Cedars-Sinai, to find out more.
SARS-CoV-2 Delta variant causes twice the hospitalisations of Alpha
A novel study has revealed that the SARS-CoV-2 Delta variant may be the deadliest, demonstrating a two-fold increased risk of hospitalisation compared to the...
Improving outcomes for children following radiation therapy
A team of experts from around the world has teamed up to improve clinical outcomes for children with cancer following radiation therapy.
Radiation therapy has...
Point-of-care medicine: the future of rapid diagnostics in healthcare
Abbott explores how point-of-care diagnostics will evolve in the wake of COVID-19, and showcases a new learning platform that aims to transform knowledge on rapid testing in primary care.